CVC Completes Acquisition of Therakos from Mallinckrodt
02 Dec 2024 //
BUSINESSWIRE
THERAKOS CELLEX Photopheresis System Receives EU MDR CE Certification
03 Sep 2024 //
PR NEWSWIRE
Mallinckrodt Sells Therakos® To CVC For $925 Million
06 Aug 2024 //
PR NEWSWIRE
Mallinckrodt, Terumo BCT announce UVADEX approval in Australia
31 Oct 2019 //
BIOSPECTRUMASIA
Mallinckrodt pays $1.2bn for Sucampo Pharma
03 Jan 2018 //
PMLIVE
Mallinckrodt to buy immunotherapy company Therakos for around $1.3 billion
11 Aug 2015 //
FIRST WORD PHARMA